Basket

0534281 - ÚOCHB 2021 RIV spa P - Patent Document
Mackman, R. - Jansa, Petr - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Lansdon, E. - Šimon, Petr
Derivados de quinazolina usados para tratar el virus de inmunodeficiencia humana (VIH).
[Quinazoline derivatives used to treat HIV.]
2019. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 27.08.2019. Patent Number: MX367574
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20190827&DB=&locale=en_EP&CC=MX&NR=367574B&KC=B&ND=4
Permanent Link: http://hdl.handle.net/11104/0312554